Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesReassessment of the Growth Hormone Status in Young Adults with Childhood-Onset Growth Hormone Deficiency: Reappraisal of Insulin Tolerance Testing
Journal of Clinical Endocrinology and Metabolism, 10/29/09
Secco A et al. – The adopted peak GH to ITT below 5.62 microg/liter is an accurate diagnostic cutoff point for HLGHD in young adults with COGHD. In addition, IGF–I is a reliable marker providing information about the severity of GHD. Careful follow–up is required for subjects with discordant ITT and IGF–I results.
Related Articles
Depressive tendency in children with growth hormone deficiency
Journal of Paediatrics and Child Health, 10/23/09
Relevance Score: 83%
Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement
Metabolism-Clinical and Experimental, 10/26/09
Relevance Score: 82%
A Molecular Basis for Variation in Clinical Severity of Isolated Growth Hormone Deficiency Type II
Journal of Clinical Endocrinology and Metabolism, 10/29/09
Relevance Score: 81%
Hypopituitarism due to sports related head trauma and the effects of growth hormone replacement in retired amateur boxers
Pituitary, 10/29/09
Relevance Score: 81%
Growth without Growth Hormone and Similar Dysmorphic Features in Three Patients with Sporadic Combined Pituitary Hormone Deficiencies
Hormone Research, 10/27/09
Relevance Score: 81%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Sponsor
Article Search
Sponsor